Australia Últimas notícias

EQ Resources Limited (ASX:EQR) has officially terminated its bid to acquire 100% of the ferrotungsten producer Tungsten Metals Group Limited (TMG Group).

Alvo Minerals Limited (ASX: ALV) has reported significant assay results from its Phase 1 drilling program at the Touro prospect within the Palma Copper-Zinc Project in Central Brazil.

TOTO Ltd., the Japanese bathroom and ceramics manufacturer listed on the Tokyo Stock Exchange, has reported a sharp rebound in earnings and outlined several operational and sustainability developments with implications for global and Australian markets.

Orbminco Limited (ASX:OB1) has officially launched an intensive ten-workstream development program for its Majestic North Gold Project in Western Australia, targeting a Final Investment Decision and regulatory lodgement by early September 2026.

Prime Minister Anthony Albanese has downplayed mounting speculation about changes to negative gearing and capital gains tax ahead of the May 12 federal budget, describing recent media reporting as “all wrong”.

The National Disability Insurance Scheme (NDIS) saw approximately $3.7 billion in funds improperly distributed last financial year, according to testimony from the scheme's integrity transformation chief, John Dardo.

Battery materials provider NOVONIX Limited (NASDAQ: NVX, ASX:NVX) has officially completed the sale of its Battery Technology Solutions (BTS) division.

Forrestania Resources Limited (ASX: FRS) has reported a maiden JORC‑compliant Inferred Mineral Resource Estimate for its Burracoppin Gold Project in Western Australia.

Peak Processing Limited (ASX:PKP) has secured binding commitments to raise A$2.4 million through the issuance of unsecured loan notes.

Tennant Minerals Ltd (ASX: TMS) has released diamond drilling results from its 100 per cent owned Barkly Project in the Northern Territory, identifying further mineralization at the Bluebird discovery.

SkyCity Entertainment Group Limited (ASX:SKC) has lowered its financial expectations for the remainder of the 2026 fiscal year, citing a downturn in consumer discretionary spending across its Australian and New Zealand operations.

ResMed Inc. (NYSE: RMD, ASX: RMD) has released its financial results for the third quarter of fiscal year 2026, reporting an 11 per cent increase in revenue to $1.4 billion.